You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
German molecular diagnostics firm Epigenomics today reported that its first-half revenues increased 1 percent year over year, and the firm is implementing a restructuring that will include cutting its staff by nearly half.
As part of the restructuring, Silence has lowered the headcount at its Berlin research facility to 27 from 32.
Silence said that the offering, if completed, would extend its cash runway from the third quarter of this year until mid-2012.
Plasticell has formed a spinout called Progenitor Labs, which will focus on regenerative drug discovery.
The Australian gel and protein detection firm sold its US subsidiary and its flagship technology in recent months and is now targeting acquisitions moving ahead.
Collins' "bold" plan to break up NCRR to catalyze translational science is drawing fire over its process and its plans for NCRR, as well as notes of caution from seasoned senators.
It was not immediately clear what impact the move would have on the programs overseen by the unit.
An article about an acquisition topped the list of the most-read stories for the year on GenomeWeb Daily News, while restructurings, lawsuits, and one firm's IPO plans made it into the top 10.
According to the company, it is responding to "mounting cost pressures in healthcare" and to "increasing hurdles for the approval and pricing of new medicines."
The firm's Pharmaceutical Divisions will be primarily affected by the job cuts and transfers. The program is expected to result in annual cost savings of CHF2.4 billion ($2.4 billion) for Roche.
Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.
An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.
Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.
In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.